This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vanderbilt University. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: Innovations of Nicholas F Pelz
Introduction
Nicholas F Pelz is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific proteins involved in cancer.
Latest Patents
Nicholas F Pelz holds 5 patents to his name. His latest patents include the invention of substituted indole Mcl-1 inhibitors. These compounds are designed to inhibit the activity of the anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The invention also encompasses pharmaceutical compositions and methods for using these compounds in the treatment of diseases characterized by the over-expression or dysregulation of Mcl-1 protein, such as cancer.
Career Highlights
Nicholas F Pelz is affiliated with Vanderbilt University, where he conducts research and develops innovative solutions in the pharmaceutical field. His work focuses on creating effective treatments for serious health conditions.
Collaborations
Nicholas collaborates with Zhiguo Bian, contributing to advancements in their shared research interests.
Conclusion
Nicholas F Pelz is a prominent inventor whose work in developing Mcl-1 inhibitors showcases his commitment to addressing critical health challenges. His contributions to the field of pharmaceuticals are noteworthy and continue to impact cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile